8 terminated. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Terminated 8 |
Follow Urologic Neoplasms: new trials by email Literature Review of Urologic Neoplasms trials Research Report on Urologic Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Correlation of Renal Mass Pathologic Grade and Contrast Enhanced Ultrasound (CEUS) Contrast enhanced ultrasound with Lumason - Renal Malignant Tumor | Phase 4 | Terminated | Indiana University | 12 | 2019-07-16 | 2024-10-10 |
| Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery Lidocaine Hydrochloride 0.8% in Dextrose 5% Solution, 0.9% Sodium Chloride Injection - Kidney Cancer, Prostate Cancer | Phase 4 | Terminated | University of Missouri-Columbia | 21 | 2019-02-26 | 2023-10-25 |
| Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE) Everolimus - Renal Cell Carcinoma | Phase 4 | Terminated | Mario Negri Institute for Pharmacological Research | 31 | 2015-07-01 | 2018-02-05 |
| Peri-operative Aspirin Continuation Versus Discontinuation Aspirin - Hematuria, Urinary Bladder Neoplasms | Phase 4 | Terminated | Rabin Medical Center | 50 | 2015-02-01 | 2019-04-08 |
| Hydroxyethyl Starch and Renal Function After Laparoscopic Nephrectomy Voluven (Hydroxyethyl starch 130/0,4), Sodium Chloride 9mg/ml - Kidney Cancer | Phase 4 | Terminated | Regional Hospital Holstebro | 14 | 2011-12-01 | 2014-10-09 |
| The Use of Self Retaining Sutures in Open and Laparoscopic Partial Nephrectomy Quill knotless tissue-closure device, 2-0 absorbable vicryl suture - Kidney Neoplasms | Phase 4 | Terminated | Ricardo Rendon | 65 | 2011-09-01 | 2021-08-02 |
| Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma Sunitinib (SUTENT) - Metastatic Renal Cell Carcinoma | Phase 4 | Terminated | Assistance Publique - Hôpitaux de Paris | 33 | 2008-12-01 | 2015-04-01 |
| Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib Nexavar (Sorafenib, BAY43-9006) with addition of gemcitabine or interferon, Gemcitabine or Interferon (only) - Carcinoma, Renal Cell | Phase 4 | Terminated | Bayer | 2 | 2006-08-01 | 2014-12-30 |
Carcinoma, Renal Cell (4) · Kidney Neoplasms (3) · Hematuria (1) · Neoplasms (1) · Prostatic Neoplasms (1) · Urinary Bladder Neoplasms (1)
Female Urogenital Diseases (8) · Female Urogenital Diseases and Pregnancy Complications (8) · Male Urogenital Diseases (8) · Neoplasms by Site (8) · Urogenital Diseases (8) · Urogenital Neoplasms (8) · Urologic Diseases (8) · Kidney Diseases (7) · Neoplasms (7) · Adenocarcinoma (4) · Carcinoma (4) · Kidney Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms, Glandular and Epithelial (4)
Sodium Chloride (2) · Aspirin (1) · Everolimus (1) · Gemcitabine (1) · Glucose (1) · HES 130-0.4 (1) · High-Energy Shock Waves (1) · Hydroxyethyl Starch Derivatives (1) · Interferons (1) · Lidocaine (1) · Saline Solution (1) · Single Person (1) · Solutions (1) · Sorafenib (1) · Sunitinib (1)
Assistance Publique - Hôpitaux de Paris (1) · Bayer (1) · Indiana University (1) · Mario Negri Institute for Pharmacological Research (1) · Rabin Medical Center (1) · Regional Hospital Holstebro (1) · Ricardo Rendon (1) · University of Missouri-Columbia (1)
United States (3) · Canada (1) · Denmark (1) · France (1) · Israel (1) · Italy (1)
Anne Sophie P. Kancir, MD PhD (1) · Boris Mraovic, MD (1) · Jordan Swennson, MD (1) · Marc A Lubin, MD (1) · Ricardo A Rendon, MD (1)